Chemotherapy with erlotinib or chemotherapy alone in advanced non‐small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors
SB Goldberg, GR Oxnard, S Digumarthy… - The …, 2013 - academic.oup.com
Purpose. Epidermal growth factor receptor (EGFR)‐mutant non‐small cell lung cancer has
an oncogene‐addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors …
an oncogene‐addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors …
Chemotherapy with Erlotinib or chemotherapy alone in advanced non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors.
SB Goldberg, GR Oxnard, S Digumarthy… - The …, 2013 - europepmc.org
Purpose. Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer has an
oncogene-addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors (TKIs) …
oncogene-addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors (TKIs) …
Chemotherapy with Erlotinib or chemotherapy alone in advanced non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors
SB Goldberg, GR Oxnard, S Digumarthy… - The …, 2013 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer has an
oncogene-addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors (TKIs) …
oncogene-addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors (TKIs) …
Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
SB Goldberg, GR Oxnard, S Digumarthy, A Muzikansky… - The Oncologist, 2013 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Purpose.</jats: title>< jats: p>
Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer has an …
Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer has an …
Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors.
SB Goldberg, GR Oxnard, S Digumarthy… - …, 2013 - search.ebscohost.com
Purpose: Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer has
anoncogene-addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors …
anoncogene-addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors …
[HTML][HTML] Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase …
SB Goldberg, GR Oxnard, S Digumarthy… - The …, 2013 - ncbi.nlm.nih.gov
Purpose. Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer has an
oncogene-addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors (TKIs) …
oncogene-addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors (TKIs) …
[PDF][PDF] Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non‐Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
SB Goldberg, GR Oxnard, S Digumarthy… - The …, 2013 - Wiley Online Library
Purpose. Epidermal growth factor receptor (EGFR)‐mutant non‐small cell lung cancer has
an oncogene‐addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors …
an oncogene‐addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors …
Chemotherapy with Erlotinib or chemotherapy alone in advanced non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors.
SB Goldberg, GR Oxnard, S Digumarthy… - The …, 2013 - europepmc.org
Purpose. Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer has an
oncogene-addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors (TKIs) …
oncogene-addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors (TKIs) …